ALC-919 For The Treatment Of Common Warts

NCT02483455 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Verruca Vulgaris

Interventions

DRUG: 2014-ALC-919-US
DRUG: Vehicle-Control Topical Solution

Sponsor

Veloce BioPharma LLC